Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$9,085,014
+$306,685 QoQ
Shares Held
35,772
-0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,175
of 4,676 holders
Holding Since
Dec 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WESTFIELD CAPITAL MANAGEMENT CO LP holds $691,252,397 across 8 Drug Manufacturers - General names. JNJ ranks #3 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
416,732 | $499,840,904 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
1,287,629 | $162,679,047 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
35,772 | $9,085,014 | |
| 4 | MRK |
Merck & Co., Inc.
|
53,297 | $6,848,664 | |
| 5 | AMGN |
Amgen Inc
|
17,047 | $6,173,059 | |
| 6 | PFE |
Pfizer Inc
|
162,023 | $3,901,513 | |
| 7 | ABBV |
AbbVie Inc.
|
7,854 | $1,976,380 | |
| 8 | NVO |
Novo Nordisk A S
|
15,599 | $747,816 |
All Filings in JNJ
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,085,014 | 35,772 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $8,778,329 | 35,912 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $6,888,951 | 33,288 | Shares | Sole | 2026-02-11 | |
| 2022-06-30 | $8,594,146 | 48,415 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $8,578,463 | 48,403 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $8,540,327 | 49,923 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $8,151,874 | 50,476 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $1,125,797 | 6,850 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,078,053 | 6,850 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||